HoFH, the International Clinical Collaborators Registry

This is an international registry study for people who have been diagnosed with homozygous familial hypercholesterolemia (HoFH). HoFH is a rare, inherited condition in which the body cannot properly remove LDL (bad) cholesterol from the blood, leading to dangerously high cholesterol levels from birth and a very high risk of early heart disease. The registry collects information about patients with HoFH from multiple countries to better understand how the disease progresses and how different treatments work. There is no experimental treatment involved — this study only collects medical data. You may be eligible if: - You have been diagnosed with homozygous familial hypercholesterolemia (HoFH), either by clinical assessment or genetic testing - There is no minimum or maximum age requirement You may NOT be eligible if: - You do not have a confirmed diagnosis of HoFH Talk to your doctor to see if this trial is right for you.